decisionhealth Newsletters, Coder Pink Sheets - 2003 Issue 10 (October)
The low-down on Marcaine - why you cannot bill it
Subscribe or sign in to view the full article.
Article Overview
This article reviews coverage and billing questions involving Marcaine in the setting of injection services, including Medicare policy, carrier interpretation, and orthopedic coding references. It is intended for coders, billing staff, and clinicians who need to understand when the medication may be considered separately billable versus bundled under local policy guidance.
Why This Topic Matters
Payment treatment for injectable drugs and local anesthetic use can vary by payer and policy, so misunderstanding the billing context may lead to claim denials or inconsistent reporting. The article helps readers compare Medicare guidance, carrier policy, and orthopedic reference materials when evaluating injection-related claims.
Article Sections
-
The low-down on Marcaine – why you cannot bill it
Introduces the billing question involving Marcaine and discusses how payer policy and Medicare guidance affect reporting in injection-related services. It also references orthopedic coding guidance and a clinical billing scenario.
What You Will Learn
- How the article frames billing questions involving Marcaine in injection services
- Why payer and carrier policies matter for injectable medications used with procedures
- How Medicare and orthopedic reference guidance are presented in the discussion
- What general documentation and policy considerations are raised for related claims
Who Should Read This
- Medical coders
- Billing staff
- Physicians
- Orthopedic practices
- Practice managers
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com